Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sino-U.S. Collaboration On Drug Standards

This article was originally published in PharmAsia News

Executive Summary

The Chinese Pharmacopoeia Commission and the U.S. Pharmacopeia Convention jointly hosted the third Sino-U.S. pharmacopoeia summit in Tianjin earlier this month. With the theme of drug quality control and standards, the summit aimed at improving communication and cooperation in drug standards between both nations. All projects in an MOU signed by ChPC and USP last March are underway, some of which are in the implementation stage (PharmAsia News, Sept. 17, 2007). ChPC Secretary-General Wu Zhen pointed out that the two countries should enhance collaboration and coordination in the field of traditional medicine. USP CEO Roger Williams expressed hope that the American standards-setting organization's development in South East Asia will be boosted by greater Chinese support in TCM standards formulation. (Click here for more - Chinese Language)

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts